Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.

Source:http://linkedlifedata.com/resource/pubmed/id/17285289

Download in:

View as

General Info

PMID
17285289